|Number of pages||2|
|Early online date||28 Apr 2022|
|Publication status||Published - Jul 2022|
Bibliographical noteFunding Information:
KM has been paid honoraria by various NHS Trusts, Ethicon Inc, Medtronic Inc, Olympus Inc, and Gore Inc for educational activities related to bariatric surgery. AAT reports grants from Novo Nordisk, personal fees from Novo Nordisk, non-financial support from Novo Nordisk, personal fees from Eli Lilly, non-financial support from Eli Lilly, personal fees from Janssen, personal fees from AstraZeneca (AZ), non-financial support from AZ, non-financial support from Impeto medical, non-financial support from Resmed, non-financial support from Aptiva, personal fees from BI, non-financial support from BI, personal fees from BMS, nonfinancial support from BMS, personal fees from NAPP, non-financial support from NAPP, personal fees from MSD, non-financial support from MSD, personal fees from Nestle, personal fees from Gilead, grants from Sanofi, and personal fees from Sanofi outside the submitted work. AAT is currently an employee of Novo Nordisk. Novo Nordisk had no role in this publication. SA has received a speaker honorarium from Johnson & Johnson for educational events. HMP has received speaker honoraria from Johnson & Johnson and Novo Nordisk for educational events, honoraria from Novo Nordisk for written educational materials, and participated in a roundtable discussion supported by Nutricia (no honorarium received).
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Nutrition and Dietetics